PHENYTOIN AGE-DOSE-CONCENTRATION RELATIONSHIP IN CHILDREN

被引:13
作者
SUZUKI, Y
MIMAKI, T
COX, S
KOEPKE, J
HAYES, J
WALSON, PD
机构
[1] CHILDRENS HOSP,DEPT PEDIAT,DIV CLIN PHARMACOL TOXICOL,700 CHILDRENS DR,COLUMBUS,OH 43205
[2] CHILDRENS HOSP,DEPT LAB MED,DIV TDM TOX,COLUMBUS,OH 43205
[3] CHILDRENS HOSP,DEPT PHARM,COLUMBUS,OH 43205
[4] CHILDRENS HOSP,RES FDN,COLUMBUS,OH 43205
[5] OSAKA UNIV,SCH MED,DEPT PHARM,OSAKA,JAPAN
[6] OSAKA MED COLL,DEPT PEDIAT,OSAKA,JAPAN
关键词
PHENYTOIN; CHILDREN; CONCENTRATION; DOSE RATIO;
D O I
10.1097/00007691-199404000-00006
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A list (n = 423) of phenytoin steady-state concentrations from children taking phenytoin alone or in combination with other drugs (n = 308) was obtained from our therapeutic drug monitoring database (1984-1990). Only 43% of concentrations were within the commonly accepted ''therapeutic'' or ''reference'' range (10-20 mg/L). Age-dose-concentration relationships showed that while occasional concentrations were above 20 mg/L, many patients receiving commonly recommended pediatric phenytoin doses (4-8 mg/kg/day) achieved concentrations below the reference range, especially children under 3 years of age. Michaelis-Menten pharmacokinetic parameters, maximal elimination rate (V(max)) and Michaelis constant (K(m)), were evaluated for patients with at least two steady-state concentrations measured for two or more different daily doses. Comedication with other drugs had no effect on either V(max) or K(m) for phenytoin. V(max) appeared to decrease significantly with age, but there was no age relationship for K(m).
引用
收藏
页码:145 / 150
页数:6
相关论文
共 14 条
[1]  
BRUNI J, 1988, TXB CLIN APPLICATION, P253
[2]  
CHIBA K, 1980, J PEDIATR-US, V96, P479
[3]  
COHEN SN, 1987, NELSON TXB PEDIATRIC, P1531
[4]  
COLE CH, 1984, HARRIET LANE TXB, P172
[5]   PROVIDING EFFECTIVE THERAPEUTIC DRUG-MONITORING SERVICES [J].
COX, S ;
WALSON, PD .
THERAPEUTIC DRUG MONITORING, 1989, 11 (03) :310-322
[6]   NON-LINEAR KINETICS OF PHENYTOIN IN CHILDREN [J].
DODSON, WE .
NEUROLOGY, 1982, 32 (01) :42-48
[7]   RAPID ANTICONVULSANT MONITORING IN AN EPILEPSY CLINIC [J].
HOUTMAN, PN ;
HALL, SK ;
GREEN, A ;
RYLANCE, GW .
ARCHIVES OF DISEASE IN CHILDHOOD, 1990, 65 (03) :264-268
[8]  
KOREN G, 1984, THER DRUG MONIT, V6, P11
[9]   THERAPEUTIC DRUG-MONITORING OF PHENYTOIN - RATIONALE AND CURRENT STATUS [J].
LEVINE, M ;
CHANG, T .
CLINICAL PHARMACOKINETICS, 1990, 19 (05) :341-358
[10]  
LUDDEN TM, 1976, LANCET, V1, P307